Track the Orion share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Healthcare & Pharma sector, Orion has published 93 reports. Market capitalisation: €10.1bn. The latest transaction was reported on 4 May 2026 (Purchase). Among the most active insiders: Satu Ahomäki. Every trade is free.
93
Insider Decl.
0
Thresholds
€559,205
76 ops.
Buy Volume
€3m
14 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Orion Buy (bullish), based on 6 analysts. Average price target: €74.33.
25Σ signal
Buys €559,205€3m Sells
Fundamental score
Ranked 4,223 of 25,596 companies
69.1
score / 100
Value
51
Quality
88
FCF yld2.2%
Earn yld4.9%
EV/EBITDA15.1x
ROE48%
Gross mgn64%
Net mgn26%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Orion is a company specializing in the healthcare and pharmaceutical sector, providing a range of pharmaceutical products and health services. It is listed on the XHEL market.